Markussen Battle (jeffjaguar9)

We found that throughout the day and seasonally coyotes shifted foraging behavior and altered behavior and resource choices to avoid moving across what we could be a challenging landscape. These changes in behavior suggest that coyotes have a complex response to land cover, terrain, and linear corridors that are not only scale dependent but also vary by behavior, diel period, and season. By examining the resource selection across three axes (behavior, time of day, and season), we have a more nuanced understanding of how a predator balances the cost and benefits of a stochastic environment. Botulinum neurotoxin type A (BoNT-A) is an effective pharmacological treatment for the management of cervical dystonia (CD) that requires repeated administration at variable intervals. We explored patient perceptions of the impact of CD and the waning of BoNT-A therapeutic effects. An internet-based survey was conducted through Carenity, a global online patient community, from May to September 2019. Eligible respondents were adults with CD who had ≥ 2 previous BoNT-A injections. 209 respondents (81% females; mean age of 49.7years) met the screening criteria. The mean BoNT-A injection frequency was 3.9 injections/year. The mean reported onset of BoNT-A therapeutic effect was 11.7days and the time to peak effect was 4.5weeks. Symptom re-emergence between injections was common (88%); the time from injection to symptom re-emergence was 73.6days (~ 10.5weeks). Treatment was not reported to completely abolish symptoms, even at peak effect. However, symptom severity was rated (0 = no symptoms; 10 = very strong symptoms) as lowest at the peak of treatment effects (mean scores ~ 3/10), increasing as the effects of treatment start waning (~ 5.5/10) and was strongest one day before the next session (~ 7-8/10). The impact of CD on quality of life followed the same 'rollercoaster' pattern. This survey highlights the burden of CD symptoms, even in patients undergoing regular treatment. Symptom re-emergence is common and has significant impact on daily activities and quality of life. Greater awareness of the therapeutic profile of BoNT-A treatment should lead to better informed therapeutic discussions and planning. This survey highlights the burden of CD symptoms, even in patients undergoing regular treatment. Symptom re-emergence is common and has significant impact on daily activities and quality of life. Greater awareness of the therapeutic profile of BoNT-A treatment should lead to better informed therapeutic discussions and planning.Older people with frailty and health crises have complex physical and social needs. Modern emergency care systems are fast-flowing, using protocols optimised for single-problem presentations. Systems must incorporate individualised care to best serve people with multiple problems. Healthcare quality is typically appraised with service metrics, such as department length of stay and mortality. Worldwide, patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) are increasingly used in research, service development and performance evaluation, paving the ground for their use to support individual clinical decision-making. The PROMs and PREMs are person-centred metrics, which inform healthcare decisions at the individual level and which at the strategic level drive improvement through comparison of interprovider effectiveness. To date, there is no PROM or PREM specifically developed for older people with frailty and emergency care needs.This letter notifies the readers of the Dysphagia journal of an error in the original published version of this manuscript, for which a previously available open source spreadsheet tool had been used to calculate the position of the hyoid bone or larynx on lateral view videofluoroscopic images. An error in the mathematical formula built into the spreadsheet resulted in a reversal of the results for the X and Y plane